Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Adapting an Expanded Access program to enable investigational treatments for COVID-19

Journal of Clinical and Translational Science(2022)10.1017/cts.2022.403Source: DataRank Database

Adapting an Expanded Access program to enable investigational treatments for COVID-19 is a research paper published in Journal of Clinical and Translational Science (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Ellen Champagne,Misty Gravelin ORCID,Jamie Racklyeft,Kevin J. Weatherwax ORCID,Elias Samuels ORCID

Live enrichment

PubMed:35836783 PMC:PMC9274384 OpenAlex:https://openalex.org/W4280524936

NCATS NIH HHS

Grant: U01 TR002488

National Institutes of Health

Grant: 5U01TR002488-03

TEAMSS – Transforming Expanded Access to Maximize Support & Study

National Institutes of Health

Grant: 5UL1TR002240-02

Michigan Institute for Clinical and Health Research (MICHR)

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/D62918222B1BE3EE7596A51FE14DDEC7/S2059866122004034a.pdf/div-class-title-adapting-an-expanded-access-program-to-enable-investigational-treatments-for-covid-19-div.pdf

publisherhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/D62918222B1BE3EE7596A51FE14DDEC7/S2059866122004034a.pdf/div-class-title-adapting-an-expanded-access-program-to-enable-investigational-treatments-for-covid-19-div.pdf

publisherhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/S2059866122004034

journalhttps://doi.org/10.1017/cts.2022.403

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35836783

Fields of Study

Health and Medical Research ImpactsHealth Systems, Economic Evaluations, Quality of LifeHealth Policy Implementation Science03 medical and health sciences0302 clinical medicine

Keywords

Translational scienceTranslational researchCoronavirus disease 2019 (COVID-19)Knowledge translationPsychological interventionProtocol (science)Medical educationMedicinePandemicData collectionMEDLINEPolitical scienceNursingAlternative medicineKnowledge managementComputer scienceSociologyCtsaExpanded AccessCovid-19Retrospective Case StudiesClinical Translational Science AwardRTranslational Science Case Study

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Industry, innovation and infrastructure